Clinical outcome of prasugrel compared with clopidogrel

Clinical outcome of prasugrel compared with clopidogrel - Clinical outcome of prasugrel

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000018133

Enrollment

600

Registered

2015-07-01

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with ischemic heart disease who underwent PCI with low-dose aspirin and thienopyridine in Kyoto university hospital between May 2013 and May 2015.

Exclusion criteria

Exclusion criteria: Contraindication of prasugrel or clopidogrel

Design outcomes

Primary

Measure	Time frame
incidence of non-fatal myocardial infarction or stent thrombosis at 30 days	—

Secondary

Measure	Time frame
all cause death, ischemic stroke, hemorrhagic stroke, any bleeding events or rug allergy.	—

Countries

Japan

Contacts

Public ContactJunichi Tazaki

Graduate School of Medicine, Kyoto University Department of Cardiovascular Medicine

jun1@kuhp.kyoto-u.ac.jp075-751-3188

Outcome results